BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Sydnexis Announces Positive CHMP Opinion in Europe for SYD-101 for Slowing the Progression of Pediatric Myopia

  April 1, 2025

   · 

  3 min read
• Press Releases

  Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis

  April 1, 2025

   · 

  6 min read
• Press Releases

  REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies

  April 1, 2025

   · 

  2 min read
• Press Releases

  Life Spine, Inc. Appoints Richard Mueller as President & Chief Executive Officer

  April 1, 2025

   · 

  1 min read
• Press Releases

  LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

  April 1, 2025

   · 

  1 min read
• Press Releases

  Cardiol Therapeutics Announces Year-End 2024 Update on Operations

  April 1, 2025

   · 

  12 min read
• Press Releases

  Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

  April 1, 2025

   · 

  4 min read
• Press Releases

  Recursion to Participate in Upcoming Investor Conference

  April 1, 2025

   · 

  1 min read
• Press Releases

  BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor, in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors

  April 1, 2025

   · 

  2 min read
• Press Releases

  Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference

  April 1, 2025

   · 

  1 min read